XML 33 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders' Equity (Tables)
9 Months Ended
Sep. 30, 2025
Equity [Abstract]  
Schedule of RSU, PRSU, and MYPSU Awards Activity
The following table summarizes the RSU, performance based restricted stock units ("PRSU"), and multi-year performance restricted stock units ("MYPSU") activity for the three and nine months ended September 30, 2025:
RSU
Number
of
Shares
Grant Date
Fair
Value
per share
PRSU
Number
of
Shares
Grant Date
Fair
Value
per share
MYPSU
Number
of
Shares
Grant Date
Fair
Value
per share
Unvested at December 31, 2024915,152$128.7 210,044$104.3 285,880$88.6 
Granted255,368173.9 155,565187.8 — 
Vested(145,509)137.5 (53,090)167.8 — 
Forfeited(16,236)113.3 — — 
Unvested at March 31, 20251,008,775$139.1 312,519$135.1 285,880$88.6 
Granted80,208167.9 — — 
Vested(187,281)140.1 — — 
Forfeited(13,782)165.8 — — 
Unvested at June 30, 2025887,920$141.1 312,519$135.1 285,880$88.6 
Granted63,122197.0 — — 
Vested(159,573)148.2 — — 
Forfeited(4,127)166.2 — — 
Unvested at September 30, 2025787,342$143.9 312,519$135.1 285,880$88.6 
Schedule Of Share-Based Payment Arrangement, Shares Withheld For Tax Withholding Obligation
The following summarizes the number and value of the shares withheld for employee taxes:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
(in thousands, except share data)
Shares withheld for taxes62,573 86,593 204,952 257,599 
Amount withheld for taxes$13,984 $12,198 $41,269 $32,566 
Schedule of Stock-Based Compensation Expense
The following table presents the detail of stock-based compensation expense amounts included in the condensed consolidated statement of operations for each of the periods presented:
Three Months Ended
September 30,
Nine Months Ended
September 30,
2025202420252024
(in thousands)
Equity based awards
Cost of revenue$740 $470 $2,134 $961 
Research and development10,070 8,526 30,272 25,762 
Selling, general and administrative13,084 11,710 39,508 35,801 
$23,894 $20,706 $71,914 $62,524 
Liability based awards - to be settled in equity
Cost of revenue$91 $25 $223 $41 
Research and development1,415 866 2,938 2,220 
Selling, general and administrative2,357 1,215 4,053 2,646 
$3,863 $2,106 $7,214 $4,907 
Total stock-based compensation expense - equity and liability based$27,757 $22,812 $79,128 $67,431 
Stock-based compensation expense recorded to additional paid-in capital
Equity based awards$23,894 $20,706 $71,914 $62,524 
Liability based awards - settled in equity976 1,009 8,414 3,633 
Stock-based compensation expense capitalized to inventory(159)200 (338)1,005 
Total stock-based compensation expense recorded to additional paid-in capital$24,711 $21,915 $79,990 $67,162 
Schedule of Unrecognized Compensation Costs and Related Weighted Average Period Of Recognition
The following table presents the unrecognized compensation costs and related weighted average period of recognition as of September 30, 2025:
Unrecognized Compensation Costs (in millions)Weighted Average Period of Recognition (in years)
RSUs$94.8 2.1
PRSUs$22.9 1.2
MYPSUs$0.5 0.3
Liability-based awards$6.1 0.5